Wells Fargo’s Fibrocell Science Inc. FCSC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,568
| Closed | -$7K | – | 7003 |
|
|
2019
Q3 | $7K | Hold |
2,568
| – | – | ﹤0.01% | 6017 |
|
|
2019
Q2 | $4K | Hold |
2,568
| – | – | ﹤0.01% | 6094 |
|
|
2019
Q1 | $5K | Hold |
2,568
| – | – | ﹤0.01% | 5759 |
|
|
2018
Q4 | $4K | Buy |
2,568
+2,034
| +381% | +$4.07K | ﹤0.01% | 6126 |
|
|
2018
Q3 | $1K | Sell |
534
-185
| -26% | -$399 | ﹤0.01% | 6349 |
|
|
2018
Q2 | $2K | Sell |
719
-7
| -1% | -$20 | ﹤0.01% | 6216 |
|
|
2018
Q1 | $2K | Buy |
726
+2
| +0.3% | +$7 | ﹤0.01% | 6231 |
|
|
2017
Q4 | $2K | Buy |
724
+334
| +86% | +$2.92K | ﹤0.01% | 6219 |
|
|
2017
Q3 | $6K | Buy |
390
+7
| +2% | +$113 | ﹤0.01% | 6000 |
|
|
2017
Q2 | $8K | Buy |
383
+48
| +14% | +$592 | ﹤0.01% | 5832 |
|
|
2017
Q1 | $3K | Buy |
335
+133
| +66% | +$1.48K | ﹤0.01% | 6133 |
|
|
2016
Q4 | $2K | Buy |
202
+19
| +10% | +$204 | ﹤0.01% | 6121 |
|
|
2016
Q3 | $2K | Hold |
183
| – | – | ﹤0.01% | 6069 |
|
|
2016
Q2 | $3K | Sell |
183
-767
| -81% | -$23.9K | ﹤0.01% | 5918 |
|
|
2016
Q1 | $35K | Sell |
950
-707
| -43% | -$28.2K | ﹤0.01% | 5349 |
|
|
2015
Q4 | $113K | Buy |
1,657
+1,579
| +2,024% | +$113K | ﹤0.01% | 4833 |
|
|
2015
Q3 | $5K | Sell |
78
-7
| -8% | -$620 | ﹤0.01% | 5871 |
|
|
2015
Q2 | $6K | Sell |
85
-30
| -26% | -$2.02K | ﹤0.01% | 5980 |
|
|
2015
Q1 | $8K | Buy |
115
+112
| +3,733% | +$7.21K | ﹤0.01% | 5720 |
|
|
2014
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 6519 |
|
|
2014
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 6437 |
|
|
2014
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 6377 |
|
|
2014
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 6187 |
|
|
2013
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 6032 |
|
|
2013
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 5935 |
|
|
2013
Q2 | $0 | Buy |
+3
| New | +$248 | ﹤0.01% | 5762 |
|
Wells Fargo's FCSC Position: Q4 2019 in Review
Wells Fargo sold out of Fibrocell Science Inc. (FCSC) in Q4 2019, closing a stake of 2,568 shares — an estimated $7K sold.
Wells Fargo first reported a position in FCSC in Q2 2013 and held it in 26 quarters. The position peaked at $113K in Q4 2015. 0 funds tracked by Wall St. Rank hold FCSC as of Q4 2019.
- Wells Fargo reported no remaining Fibrocell Science Inc. position as of Q4 2019 after selling out during the quarter.
- Wells Fargo sold 2,568 Fibrocell Science Inc. shares in Q4 2019, an estimated $7K.
- Wells Fargo first reported a position in Fibrocell Science Inc. in Q2 2013 and held it in 26 quarters.
- Wells Fargo's Fibrocell Science Inc. position peaked at $113K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2019.
Based on Wells Fargo's 13F filing for Q4 2019, filed 14 Feb 2020.